Additionally, we also assessed the link between RHBDF2 and clinicopathological parameters and found that RHBDF2 overexpression was significantly linked to tumor histology, stage, lymph node metastasis and TP53 mutation. This evidence concerns the gene RHBDF2 and neoplasm.